Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
The Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
Relazione finanziaria semestrale al 30 giugno 2022 Apertura del quarto periodo di esercizio dei “Warrant Ulisse BIiomed S.p.A. 2021-2026”: dal 1 al 31 ottobre 2023
